Categories: News

Adhesive bonding solutions for wearables applications on skin – made by Lohmann

NEUWIED, Germany, May 18, 2022 /PRNewswire/ — Over the last few years and during the global pandemic, the demand for wearables and longwear applications in the medical industry has significantly increased. For example, in diagnostics, monitoring and consumer health, the need for reliable bonding solutions for these devices increased as well. As sensitive and stressed skin (children, athletes, elderly people) especially demands for sensitive and flexible products, Lohmann designed and released a new portfolio of bonding solutions. They offer high breathability, water resistance as well as a residue-free and painless removability.

With highly demanding requirements to the long-lasting adhesion to skin, permanent changes and fluctuating external influences, low surface energy, rough textures or sweat, the Lohmann wearables adhesive solutions are engineered and tailored to medical industry’s applications and design requirements. No matter if applied to mobile cardiac telemetry (MCT), continuous glucose or temperature measurement (CGM and CTM), insulin patch pumps or large volume injectors, for short- or long-term use, single- or double-sided, each bonding solution is biocompatible and allows for ever thinner and more flexible wearables. This gives patients a higher level of comfort and mobility.

The Lohmann product portfolio supports connectivity features of wearables via electrical conductivity, i.e. for quantifying symptoms via (remote) monitoring devices and thus predicting and preventing future acute episodes. As patients are becoming stakeholders in their own healthcare journey due to remote monitoring and possible recovery at home, costs for the healthcare system, which is affected by nursing shortage and shrinking budgets, are significantly reduced, too. An increasingly important aspect in an ageing population and with chronic diseases on the rise.

Meeting the needs of the medical and healthcare industry, Lohmann provides in-house state-of-the-art capabilities, which include adhesive formulation, coating, casting and extrusion as well as clean-room conversion, laboratories and testing as well as die-cutting. The Neuwied-based adhesive technology specialist is certified in accordance with EN ISO 13485.

Founded in 1851, the family-owned company Lohmann GmbH & Co KG is considered a specialist in adhesive bonding technology. With annual sales of around 670 million euros, more than 1,800 employees in 24 sites and exclusive sales partners in over 50 countries, Lohmann is active around the globe. The headquarters is located in Neuwied, Germany.

The company offers high-tech adhesive solutions for applications primarily in the automotive, medical, consumer goods, electronics and graphical industries. Lohmann engineers’ solutions range from multifunctional adhesive tapes to precision die-cut parts and process integration.

Lohmann GmbH und Co. KG
PR & Communications Manager
Sonja Schöbitz M.A.
Irlicher Str. 55
56567 Neuwied
Tel: +49 (0) 2631 34 6040
Sonja.Schoebitz@lohmann-tapes.com

Photo: https://healthtechnologynet.com/wp-content/uploads/2022/05/Lohmann_Bonding_Solutions.jpg
Logo: https://healthtechnologynet.com/wp-content/uploads/2022/05/Lohmann_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/adhesive-bonding-solutions-for-wearables-applications-on-skin–made-by-lohmann-301549293.html

SOURCE Lohmann GmbH & Co. KG

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

6 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

7 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

7 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

8 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

9 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

10 hours ago